918博天堂(中华区)官方网站

External PARTNERSHIP

Company Profile
2013

Huaota licensed in four biosimilar products from US Oncobiologics Inc. 

including Adalimumab monoclonal antibody biosimilar (project code ‘HOT-3010’) and Avastin monoclonal antibody biosimilar (project code ‘HOT-1010’)

2013
2017
Huaota reached a license agreement with Eutilex CO., LTD.
of HOT-1030 project, a CD137 monoclonal antibody.
2017
2019

Huaota entered into an agreement with Shanghai Junshi Biosciences Co., Ltd and Junshi acquired the Avastin monoclonal antibody biosimilar (project code "HOT-1010") from Huaota for ¥90 million.HOT-1010

2019
友情链接: